Select what you are looking for, enter your search-term, and enable the years you want to scan.
johnson & johnson del ecuador sa is a VISINE ORIGINAL 1X15ML ECUADOR CODES , VISINE ORIGINAL 1X15ML ECUADOR CODES and VISINE EXTRA EYEDROPS SHIPMENT company. This page shows the major manufacturers of JOHNSON & JOHNSON DEL ECUADOR SA. Results are limited to 15 suppliers, if you want to see more suppliers visit the manufacturers page of JOHNSON & JOHNSON DEL ECUADOR SA.
28-14 av coruna n y manuel iturrey quito p 170150 ec
| Imports in 2021 |
|---|
37718 KG |
145 CTNS
|
10 orders
|
janssen pharmaceutica nv support from belgium. Their major products are PHARMACEUTICALS TYL INF SUSP GRAPE VISINE RED EYE COMF LOADED ONTO, PHARMACEUTICALS VISINE MULTYSYMP RELF VISINE ANTIHIST RELIEF LOADED ONTO PALLE, PHARMACEUTICALS VISINE MULTYSYMP RELF VISINE ANTIHIST RELIEF LOADED ONTO PALLE . johnson & johnson del ecuador sa gets its VISINE ORIGINAL 1X15ML ECUADOR CODES, VISINE ORIGINAL 1X15ML ECUADOR CODES, VISINE EXTRA EYEDROPS SHIPMENT from janssen pharmaceutica nv.
Between 2014 and 2017, johnson & johnson del ecuador sa ordered 10 shipments from janssen pharmaceutica nv.
In 2014, johnson & johnson del ecuador sa made up 0% of janssen pharmaceutica nv's sales to USA. This number went to 0% by 2015 and 0% in 2016. In 2017, johnson & johnson del ecuador sa made up 0% of janssen pharmaceutica nv’s sales to USA
1.PHARMACEUTICALS TYL INF SUSP GRAPE VISINE RED EYE COMF LOADED ONTO
2.PHARMACEUTICALS VISINE MULTYSYMP RELF VISINE ANTIHIST RELIEF LOADED ONTO PALLE
3.PHARMACEUTICALS VISINE MULTYSYMP RELF VISINE ANTIHIST RELIEF LOADED ONTO PALLE
4.PHARMACEUTICALS LOADED ONTO MOTRI INF SUDRP BRY VISINE D-EYE
5.PHARMACEUTICALS VISINE A.C. VISINE TEARS VISINE HYDR COMF TYL INF
1.VISINE ORIGINAL 1X15ML ECUADOR CODES
2.VISINE ORIGINAL 1X15ML ECUADOR CODES
3.VISINE EXTRA EYEDROPS SHIPMENT
4.VISINE ORIGINAL 1X15ML ECUADOR SHIPMENT CODES
5.VISINE ORIGINAL 1X15ML ECUADOR CODES
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 1 | 0 | 0 | 0 |